Vetoquinol (PA:VETO) — Stock Price
Vetoquinol (PA:VETO) is currently trading at €72.10 EUR, down 0.69% today. Over the past 52 weeks, shares have ranged between €67.20 and €91.00. This page tracks Vetoquinol's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see VETO company net worth.
Vetoquinol (VETO) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Vetoquinol's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Vetoquinol Income Statement — Revenue, Profit & Earnings by Year
Vetoquinol's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €539.20 Million | €529.27 Million | €539.78 Million | €521.27 Million | €427.47 Million |
| Cost of Revenue | €151.75 Million | €237.89 Million | €367.41 Million | €353.90 Million | €303.49 Million |
| Gross Profit | €387.45 Million | €291.38 Million | €172.37 Million | €167.37 Million | €123.98 Million |
| Research & Development | €2.37 Million | €40.10 Million | €32.60 Million | €31.00 Million | €28.40 Million |
| SG&A | €77.98 Million | €159.44 Million | €71.95 Million | €66.62 Million | €54.06 Million |
| Total Operating Expenses | €310.13 Million | €217.12 Million | €93.05 Million | €206.37 Million | €71.49 Million |
| Operating Income | €77.32 Million | €74.26 Million | €74.00 Million | €86.28 Million | €37.09 Million |
| EBITDA | €114.08 Million | €112.33 Million | €103.46 Million | €116.86 Million | €59.29 Million |
| EBIT | €82.08 Million | €77.82 Million | €71.91 Million | €83.98 Million | €33.41 Million |
| Interest Expense | €1.24 Million | €1.14 Million | €3.26 Million | €1.04 Million | €1.08 Million |
| Income Before Tax | €81.01 Million | €76.91 Million | €72.74 Million | €86.51 Million | €35.87 Million |
| Income Tax Expense | €22.33 Million | €21.34 Million | €24.74 Million | €23.77 Million | €16.64 Million |
| Net Income | €58.69 Million | €55.56 Million | €47.99 Million | €62.86 Million | €19.22 Million |
Vetoquinol Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Vetoquinol's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €744.13 Million | €692.23 Million | €651.85 Million | €624.56 Million | €646.09 Million |
| Total Current Assets | €421.18 Million | €363.39 Million | €308.61 Million | €273.69 Million | €307.16 Million |
| Cash & Equivalents | €1.00K | — | — | — | — |
| Short-term Investments | €20.82 Million | €-1.32 Million | €28.28 Million | €15.34 Million | €1.00K |
| Net Receivables | €92.56 Million | €97.16 Million | €83.78 Million | €85.80 Million | €87.68 Million |
| Inventory | €112.29 Million | €103.54 Million | €116.09 Million | €111.59 Million | €85.53 Million |
| Property, Plant & Equipment | €92.60 Million | €89.70 Million | €84.65 Million | €72.99 Million | €72.27 Million |
| Goodwill | €76.41 Million | €75.04 Million | €76.17 Million | €83.46 Million | €79.86 Million |
| Total Liabilities | €168.20 Million | €165.12 Million | €167.19 Million | €183.21 Million | €274.26 Million |
| Total Current Liabilities | €141.53 Million | €139.39 Million | €140.39 Million | €156.77 Million | €239.55 Million |
| Long-term Debt | €178.00K | €172.00K | €179.00K | €187.00K | €176.00K |
| Net Debt | €-185.21 Million | €-129.84 Million | €-76.29 Million | €-53.62 Million | €-4.58 Million |
| Total Stockholder Equity | €575.84 Million | €527.01 Million | €484.57 Million | €441.26 Million | €371.75 Million |
| Retained Earnings | €58.69 Million | €55.56 Million | €47.99 Million | €62.86 Million | €19.22 Million |
Vetoquinol Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Vetoquinol generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €85.83 Million | €89.39 Million | €62.85 Million | €89.72 Million | €92.23 Million |
| Capital Expenditures | €17.68 Million | €19.01 Million | €22.50 Million | €32.40 Million | €145.46 Million |
| Free Cash Flow | €68.15 Million | €70.38 Million | €40.36 Million | €57.31 Million | €-53.23 Million |
| Investing Cash Flow | €-15.65 Million | €-18.88 Million | €-21.52 Million | €-33.45 Million | €-145.14 Million |
| Financing Cash Flow | €-16.03 Million | €-15.50 Million | €-16.06 Million | €-120.85 Million | €101.99 Million |
| Dividends Paid | €10.06 Million | €9.46 Million | €9.46 Million | €5.91 Million | €4.49 Million |
| Stock-Based Compensation | €0.00 | €0.00 | €51.00K | €129.00K | €78.00K |
| Depreciation | €30.62 Million | €34.50 Million | €5.69 Million | €31.61 Million | €46.15 Million |
| Change in Cash | €56.23 Million | €52.62 Million | €25.48 Million | €-61.23 Million | €45.75 Million |
Vetoquinol Earnings History — EPS Actual vs. Analyst Estimates
Track Vetoquinol's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 09, 2026 | — | — | — |
| Mar 27, 2026 | — | — | — |
| Oct 28, 2025 | 0.00 | 0.00 | — |
| Sep 11, 2025 | 2.13 | — | — |
| Apr 24, 2025 | 2.97 | 0.00 | — |
| Mar 20, 2025 | 0.00 | 0.00 | — |
| Oct 30, 2024 | 0.00 | 0.00 | — |
| Sep 12, 2024 | 0.00 | 0.00 | — |